Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U9LT
|
||||
| Former ID |
DIB016819
|
||||
| Drug Name |
Y-39983
|
||||
| Synonyms |
RKI-983; SNJ-1656; ROCK inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis; Rho-associated protein kinase inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Glaucoma [ICD9: 365; ICD10:H40-H42] | Phase 1/2 | [522584] | ||
| Company |
Mitsubishi Pharma Corp
|
||||
| Formula |
C16H18Cl2N4O
|
||||
| Canonical SMILES |
c1c(ccc(c1)C(=O)Nc1ccnc2c1cc[nH]2)[C@@H](C)N.Cl
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Rho associated protein kinase | Target Info | Modulator | ||
| References | |||||